Protection of transplanted pancreatic cells from an attack by the immune system is important because hundreds of diabetes patients have already had faulty cells in the pancreas replaced, but their immune system attacks the implanted cells believing it is an unwanted pathogen. This results in the patients having to take immunosuppressant drugs for the rest of their lives.
This work originates from Millman’s previous research work with Dr. Douglas Melton at the Harvard Stem Cell Institute.
Jeffrey R. Millman, Ph. D.Jeffrey Millman joined the Department of Medicine faculty and the Division of Endocrinology, Metabolism and Lipid Research in July, 2015. Millman received his Ph. D. in Chemical Engineering from the Massachusetts Institute of Technology in 2011. He completed his postdoctoral research fellowship at Harvard University with Dr. Douglas Melton, developing methods to generate functional pancreatic
Millman’s lab research is focused on the in vitro production and study of pancreatic